-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OJishW54GybCmaPaNimlbY93Yk2zgn5jxinL8GsEWlAc51uqhrsHDxar37nogWDv M+vuovk29JzYJ0Hee2Apmg== 0000950129-07-006159.txt : 20080410 0000950129-07-006159.hdr.sgml : 20080410 20071214143539 ACCESSION NUMBER: 0000950129-07-006159 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20071214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE CENTRAL INDEX KEY: 0001062822 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 760474169 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 8800 TECHNOLOGY FOREST PLACE CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 2818633000 MAIL ADDRESS: STREET 1: 8800 TECHNOLOGY FOREST PLACE CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON GENETICS INC/TX DATE OF NAME CHANGE: 20000126 CORRESP 1 filename1.htm corresp
 

[LEXICON PHARMACEUTICALS LETTERHEAD]
December 14, 2007
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention:   Mr. Mark Brunhofer
Division of Corporate Finance
     Re:   Lexicon Pharmaceuticals, Inc.
Form 10-K for the fiscal year ended December 31, 2006
Form 10-Q for the quarterly period ended September 30, 2007
File No. 000-30111
Dear Mr. Brunhofer:
     Reference is made to the comment letter dated November 16, 2007 from the Securities and Exchange Commission’s staff with respect to the above-referenced filings. We are currently preparing our responses to those comments and respectfully request an additional 5 business days, in addition to the previously requested extension of 10 business days, within which to provide you with those responses.
     Please contact me at (281) 863-3321 if you are unable to grant this requested extension or if you have any additional comments or questions concerning this letter.
         
  Very truly yours,
 		  
  /s/ Jeffrey L. Wade    
  Jeffrey L. Wade   
  Executive Vice President and General Counsel   
 

-----END PRIVACY-ENHANCED MESSAGE-----